Free Republic 3rd Qtr 2025 Fundraising Target: $81,000 Receipts & Pledges to-date: $0
0%  
Woo hoo!! 3rd Qtr 2025 FReepathon is now underway!!

Keyword: tocilizumab

Brevity: Headers | « Text »
  • Biden's America: Supply Chain Breakdown Preventing Cancer Patients from Getting Life-Saving Drugs

    10/25/2021 5:00:06 PM PDT · by UMCRevMom@aol.com · 14 replies
    www.westernjournal.com ^ | October 25, 2021 | Samantha Chang
    President Joe Biden’s inept leadership has spawned tragic tentacles as supply chain shortages threaten to kill cancer and COVID-19 patients unable to receive life-saving drugs. The FDA currently lists 109 drugs in short supply nationally. Three of the top five medications shortages are drugs used for chemotherapy, heart conditions and antibiotics. One of the scarce drugs is the anti-inflammatory tocilizumab, used by both cancer and COVID-19 patients. The scarcity has forced physicians to ration drugs. Dr. Patrick Jackson, an infectious-disease physician gives tocilizumab to chemotherapy patients while denying COVID patients because there simply isn’t enough to go around. Brian Spoehlhof,...
  • ICMR Drops Ivermectin, Hydroxychloroquine Drugs

    09/24/2021 1:52:57 AM PDT · by nickcarraway · 93 replies
    Big News Network ^ | 24th September 2021
    New Delhi [India], September 24 (ANI): Indian Council of Medical Research (ICMR)-COVID-19 National Task Force Joint Monitoring Group dropped the usage of Ivermectin and Hydroxychloroquine (HCQ) drugs from revised clinical guidelines for the management of adult COVID-19 patients. However, the new guidelines mention the use of Remdesivir and Tocilizumab in specific circumstances. Among the key guidelines which are routinely stressed include--wearing masks, physical distancing and hand hygiene. Suggesting a moderate use of other drugs like Remedesivir, the guideline advises the former to be used only in select moderate or severe Covid-19 patients on supplemental oxygen within 10 days of onset...
  • AI Identifies Drugs With Synergistic Potential to Fight COVID-19

    03/30/2020 5:46:21 PM PDT · by nickcarraway · 6 replies
    AI in Healthcare ^ | March 30, 2020 | Dave Pearson
    A healthcare AI company has spotted several unexpected, off-label drug combinations that may do the job against COVID-19. In any case, the company is offering its complete AI toolkit free of charge to drug developers working on COVID treatments. In announcing its work, Germany-based Innoplexus, which specializes in AI-based drug discovery and development, says the promising combos emerged from its processing of hundreds of studies covering thousands of patients. Most of the findings mentioned in the announcement involve the potential of the decades-old, much-discussed malaria fighter Hydroxychloroquine as used with other drugs. For example, the analysis showed that combining Chloroquine...